The global companion diagnostics market size accounted for USD 8.87 billion in 2024, grew to USD 8.87 billion in 2025 and is projected to surpass around USD 28.54 billion by 2034, representing a healthy CAGR of 12.40% between 2024 and 2034. The North America companion diagnostics market size is calculated at USD 2.86 billion in 2024 and is expected to grow at a fastest CAGR of 12.51% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Companion Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Companion Diagnostics Market, by Indication, 2024-2034
8.1.1. Cancer
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Neurological Disorders
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Cardiovascular Diseases
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Infectious Diseases
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Other Indications
8.1.5.1. Market Revenue and Forecast (2021-2034)
9.1. Companion Diagnostics Market, by Product & Service, 2024-2034
9.1.1. Assays, Kits & Reagents
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Software & Services
9.1.2.1. Market Revenue and Forecast (2021-2034)
10.1. Companion Diagnostics Market, by Technology, 2024-2034
10.1.1. Polymerase Chain Reaction
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Next-generation Sequencing
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. In Situ Hybridization
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Immunohistochemistry
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Other
10.1.5.1. Market Revenue and Forecast (2021-2034)
11.1. Companion Diagnostics Market, by Indication, 2024-2034
11.1.1. Oncology
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Neurology
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Infectious Diseases
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2021-2034)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2021-2034)
12.1. Companion Diagnostics Market, by End-User, 2024-2034
12.1.1. Pharmaceutical & Biopharmaceutical Companies
12.1.1.1. Market Revenue and Forecast (2021-2034)
12.1.2. Reference Laboratories
12.1.2.1. Market Revenue and Forecast (2021-2034)
12.1.3. Contract Research Organizations
12.1.3.1. Market Revenue and Forecast (2021-2034)
12.1.4. Other End Users
12.1.4.1. Market Revenue and Forecast (2021-2034)
13.1. North America
13.1.1. Market Revenue and Forecast, by Indication (2021-2034)
13.1.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.1.3. Market Revenue and Forecast, by Technology (2021-2034)
13.1.4. Market Revenue and Forecast, by Indication (2021-2034)
13.1.5. Market Revenue and Forecast, by End-User (2021-2034)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Indication (2021-2034)
13.1.6.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.1.6.3. Market Revenue and Forecast, by Technology (2021-2034)
13.1.6.4. Market Revenue and Forecast, by Indication (2021-2034)
13.1.6.5. Market Revenue and Forecast, by End-User (2021-2034)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Indication (2021-2034)
13.1.7.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.1.7.3. Market Revenue and Forecast, by Technology (2021-2034)
13.1.7.4. Market Revenue and Forecast, by Indication (2021-2034)
13.1.7.5. Market Revenue and Forecast, by End-User (2021-2034)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Indication (2021-2034)
13.2.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.2.3. Market Revenue and Forecast, by Technology (2021-2034)
13.2.4. Market Revenue and Forecast, by Indication (2021-2034)
13.2.5. Market Revenue and Forecast, by End-User (2021-2034)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Indication (2021-2034)
13.2.6.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.2.6.3. Market Revenue and Forecast, by Technology (2021-2034)
13.2.7. Market Revenue and Forecast, by Indication (2021-2034)
13.2.8. Market Revenue and Forecast, by End-User (2021-2034)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Indication (2021-2034)
13.2.9.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.2.9.3. Market Revenue and Forecast, by Technology (2021-2034)
13.2.10. Market Revenue and Forecast, by Indication (2021-2034)
13.2.11. Market Revenue and Forecast, by End-User (2021-2034)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Indication (2021-2034)
13.2.12.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.2.12.3. Market Revenue and Forecast, by Technology (2021-2034)
13.2.12.4. Market Revenue and Forecast, by Indication (2021-2034)
13.2.13. Market Revenue and Forecast, by End-User (2021-2034)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Indication (2021-2034)
13.2.14.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.2.14.3. Market Revenue and Forecast, by Technology (2021-2034)
13.2.14.4. Market Revenue and Forecast, by Indication (2021-2034)
13.2.15. Market Revenue and Forecast, by End-User (2021-2034)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Indication (2021-2034)
13.3.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.3.3. Market Revenue and Forecast, by Technology (2021-2034)
13.3.4. Market Revenue and Forecast, by Indication (2021-2034)
13.3.5. Market Revenue and Forecast, by End-User (2021-2034)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Indication (2021-2034)
13.3.6.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.3.6.3. Market Revenue and Forecast, by Technology (2021-2034)
13.3.6.4. Market Revenue and Forecast, by Indication (2021-2034)
13.3.7. Market Revenue and Forecast, by End-User (2021-2034)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Indication (2021-2034)
13.3.8.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.3.8.3. Market Revenue and Forecast, by Technology (2021-2034)
13.3.8.4. Market Revenue and Forecast, by Indication (2021-2034)
13.3.9. Market Revenue and Forecast, by End-User (2021-2034)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Indication (2021-2034)
13.3.10.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.3.10.3. Market Revenue and Forecast, by Technology (2021-2034)
13.3.10.4. Market Revenue and Forecast, by Indication (2021-2034)
13.3.10.5. Market Revenue and Forecast, by End-User (2021-2034)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Indication (2021-2034)
13.3.11.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.3.11.3. Market Revenue and Forecast, by Technology (2021-2034)
13.3.11.4. Market Revenue and Forecast, by Indication (2021-2034)
13.3.11.5. Market Revenue and Forecast, by End-User (2021-2034)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Indication (2021-2034)
13.4.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.4.3. Market Revenue and Forecast, by Technology (2021-2034)
13.4.4. Market Revenue and Forecast, by Indication (2021-2034)
13.4.5. Market Revenue and Forecast, by End-User (2021-2034)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Indication (2021-2034)
13.4.6.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.4.6.3. Market Revenue and Forecast, by Technology (2021-2034)
13.4.6.4. Market Revenue and Forecast, by Indication (2021-2034)
13.4.7. Market Revenue and Forecast, by End-User (2021-2034)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Indication (2021-2034)
13.4.8.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.4.8.3. Market Revenue and Forecast, by Technology (2021-2034)
13.4.8.4. Market Revenue and Forecast, by Indication (2021-2034)
13.4.9. Market Revenue and Forecast, by End-User (2021-2034)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Indication (2021-2034)
13.4.10.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.4.10.3. Market Revenue and Forecast, by Technology (2021-2034)
13.4.10.4. Market Revenue and Forecast, by Indication (2021-2034)
13.4.10.5. Market Revenue and Forecast, by End-User (2021-2034)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Indication (2021-2034)
13.4.11.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.4.11.3. Market Revenue and Forecast, by Technology (2021-2034)
13.4.11.4. Market Revenue and Forecast, by Indication (2021-2034)
13.4.11.5. Market Revenue and Forecast, by End-User (2021-2034)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Indication (2021-2034)
13.5.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.5.3. Market Revenue and Forecast, by Technology (2021-2034)
13.5.4. Market Revenue and Forecast, by Indication (2021-2034)
13.5.5. Market Revenue and Forecast, by End-User (2021-2034)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Indication (2021-2034)
13.5.6.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.5.6.3. Market Revenue and Forecast, by Technology (2021-2034)
13.5.6.4. Market Revenue and Forecast, by Indication (2021-2034)
13.5.7. Market Revenue and Forecast, by End-User (2021-2034)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Indication (2021-2034)
13.5.8.2. Market Revenue and Forecast, by Product & Service (2021-2034)
13.5.8.3. Market Revenue and Forecast, by Technology (2021-2034)
13.5.8.4. Market Revenue and Forecast, by Indication (2021-2034)
13.5.8.5. Market Revenue and Forecast, by End-User (2021-2034)
14.1. F. Hoffmann-La Roche Ltd. (Switzerland)
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Agilent Technologies, Inc. (US)
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Qiagen N.V. (Germany)
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Thermo Fisher Scientific, Inc. (US)
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Abbott Laboratories, Inc. (US)
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample